[Sudden cardiac death--a problem in cardiology today]
Related Experiment Video
Updated: Sep 19, 2026

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
1Interní kardiologická klinika FN Brno, pracovistĕ Bohunice.
Insights
Sudden cardiac death in Europe affects over 2500 people daily, primarily due to ventricular arrhythmias linked to heart disease. Risk stratification and treatments like beta-blockers and defibrillators significantly improve patient prognosis.
Area of Science:
- Cardiology
- Electrophysiology
- Public Health
Context:
- Sudden cardiac death (SCD) is a major cause of mortality in Europe, with over 2500 daily deaths.
- Malignant ventricular arrhythmias, often stemming from structural heart disease, precipitate approximately 90% of SCD cases.
- Current risk stratification identifies high-risk patient subpopulations.
Purpose:
- To outline current strategies for managing patients at high risk of sudden cardiac death.
- To highlight the effectiveness of pharmacological and non-pharmacological interventions.
Summary:
- High-risk patients identified through stratification can receive targeted treatments.
- Treatment options include chronic beta-blocker therapy, congestive heart failure management, myocardial revascularization, and cardioverter-defibrillator implantation.
- These interventions are associated with significantly better prognoses compared to conservative management.
Impact:
- Improved survival rates for patients susceptible to sudden cardiac death.
- Reduced burden of sudden cardiac death on European populations.
- Enhanced clinical management protocols for structural heart disease patients at risk of arrhythmias.
Abstract:
More than 2500 persons from European population die of sudden cardiac death every day. Nearly 90% of these cases are caused by malignant ventricular arrhythmias, which develop most frequently on the basement of structural heart disease. Some subpopulations of patients can be marked as a high risk for sudden cardiac death according to the today stratification procedures and can be treated in a pharmacological or nonpharmacological ways. The ways are as follows: a chronic therapy with beta-blockers agents, therapy of congestive heart failure, myocardial revascularization and implantation of cardioverter-defibrillator. The prognosis of patients treated in those ways in comparison with conservatively treated groups is very good.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
06:46Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
Published on: February 28, 2025
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Coronary Artery Disease III: Clinical Manifestations
Introduction Cardiac Emergencies
Cardiopulmonary Resuscitation III: AED Use
Cardiomyopathy III: Hypertrophic Cardiomyopathy